We have previously shown that populations of skeletal muscle-derived stem cells (MDSCs) exhibit sexbased differences for skeletal muscle and bone repair, with female cells demonstrating superior engrafting abilities to males in skeletal muscle while male cells differentiating more robustly toward the osteogenic and chondrogenic lineages. In this study, we tested the hypothesis that the therapeutic capacity of MDSCs transplanted into myocardium is influenced by sex of donor MDSCs or recipient. Male and female MDSCs isolated from the skeletal muscle of 3-week-old mice were transplanted into recipient male or female dystrophin-deficient (mdx) hearts or into the hearts of male SCID mice following acute myocardial infarction. In the mdx model, no difference was seen in engraftment or blood vessel formation based on donor cell or recipient sex. In the infarction model, MDSC-transplanted hearts showed higher postinfarction angiogenesis, less myocardial scar formation, and improved cardiac function compared to vehicle controls. However, sex of donor MDSCs had no significant effects on engraftment, angiogenesis, and cardiac function. VEGF expression, a potent angiogenic factor, was similar between male and female MDSCs. Our results suggest that donor MDSC or recipient sex has no significant effect on the efficiency of MDSC-triggered myocardial engraftment or regeneration following cardiac injury. The ability of the MDSCs to improve cardiac regeneration and repair through promotion of angiogenesis without differentiation into the cardiac lineage may have contributed to the lack of sex difference observed in these models.
INTRODUCTION
tissue engineering approaches to repair the injured and failing human heart. Cellular cardiomyoplasty is an emerging therapeutic Heart disease is the leading cause of death in the world, and a recent estimate from the American Heart option that has gained recognition as a strategy to repair damaged myocardium and potentially reverse many deAssociation stated that 1 in 3 American adults have a form of heart disease (30) . Heart disease includes both bilitating heart diseases (3). To date, a wide variety of cell types have been examined for suitability for cardiac congenital and acquired cardiomyopathies as well as other types of damage, including ischemic injury from repair, including skeletal myoblasts (31), smooth muscle cells (11), fibroblasts (14), resident myocardial progenimyocardial infarction. For most patients, the final therapeutic option for end-stage heart failure is heart transtors (20, 26) , mesenchymal stem cells (1, 17) , hematopoietic stem cells (2, 22) , and embryonic stem cells (19). plantation, although this is not always a viable option due to low organ availability and the comorbidities assoThere have also been numerous clinical trials using cell transplantation to repair the ischemic heart, but there ciated with long-term immunosuppression (3) . Limited donor organ availability and the low regenerative capacwere low efficiencies of transplanted cell survival and concerns regarding increased risk of clinical arrhythity of the adult heart following injury (8) has stimulated both basic science research and clinical trials to validate mias, which continue to be under investigation.
Recently a population of murine muscle-derived stem (5, 18) . Based on these results, we hypothesized that there would also be a sex difference in MDSC-induced cells (MDSCs) has been shown to have an improved regenerative capacity in bone and skeletal/cardiac muscardiac regeneration, which was supported by a recent study demonstrating sex differences in mesenchymal cles when compared to satellite cells or myoblasts (25, 29) . MDSCs are a unique cell population whose characterisstem cells for cardiac repair (6) . In the current study we investigated transplantation efficiency of MDSCs into tics, including marker profile, proliferation and differentiation kinetics, and regenerative capacity, are distinct both mdx mice and a SCID mouse model of myocardial infarction to determine if donor cell sex or recipient sex from myoblasts (9, 15) . After implantation into ischemic hearts, MDSCs display high levels of engraftment that would influence cardiac engraftment and regeneration/ repair. Our results indicate that cell and host sex is not persist over time, induce neoangiogenesis, prevent cardiac remodeling, and elicit significant improvements in a critical factor for cardiac engraftment or repair using MDSCs. cardiac function (25) . A human counterpart to MDSCs has been isolated based on cell surface markers with the MATERIALS AND METHODS human muscle-derived cells coexpressing myogenic and MDSC Isolation endothelial markers. These cells have been shown to be better than purely myogenic or endothelial cells for both Muscle-derived stem cells were isolated from the skeletal muscle repair (37) and cardiac repair following skeletal muscle of 3-week-old normal C57BL mice myocardial infarction (23).
(Jackson) using the modified preplate technique as preThe variable results noted following cellular transviously described (9, 12, 29) . Mice were anatomically plantation in most organ systems could be due to a varisexed prior to isolation. Both male and female MDSCs ety of factors, including differences in cell populations (five populations of each) were cultured in proliferation and treatment regimens, as well as other intrinsic characmedia (PM) containing Dulbecco's modified Eagle meteristics, including the sex of the cells and recipient. The dium (DMEM) (Invitrogen), 10% fetal bovine serum association between sex and cardiac morbidity and mor-(FBS) (Invitrogen), 10% horse serum, 1% penicillin/ tality is well established. The prognosis for males with streptomycin, and 0.5% chick embryo extract (Accurate heart disease is worse than in premenopause females (16, Chemical) . 36), and cardiovascular disease in women is less comIntramyocardial Cell Transplantation to mdx Mice mon and has a later average age of onset (4, 33) . Sexrelated differences in stem cell behavior have been noted
The use of animals and the surgical procedures perfor the efficiency of endothelial progenitor cells colony formed in this study were approved by the Institutional formation, mesenchymal stem cell activation and funcAnimal Care and Use Committee of the Children's Hostion, MDSC-triggered skeletal muscle repair, and stresspital of Pittsburgh (protocol 14-06). The mdx mice triggered MDSC gene expression (6, 7, 10, 13) . These re-(C57BL/10ScSn-Dmd mdx ) were bred in our institution's sults suggest that while the microenvironment plays a animal facility. Cell transplantation into mdx hearts was critical role in stem cell repair, differences in inherent performed as previously described with less than 1% stem cell characteristics, including sex, could account mortality (27, 28) . Briefly, each heart was exposed via a for some of the outcome variability noted in clinical left thoracotomy, and 1 × 10 5 MDSCs in 10 µl phostrials. Characterizing subtle but clinically relevant facphate-buffered saline (five separately isolated populators that influence the biology of cells used for cardiac tions of male and female cells) were injected into the therapy is especially important to optimize clinical transleft ventricular free wall of male or female mdx mice lation.
(12-16 weeks of age, N = 6-12 animals per MDSC Our laboratory has recently shown that female MDSCs population). Two weeks after injection, the mice were are superior to male cells for repairing skeletal muscle sacrificed, the hearts harvested and flash-frozen in liquid (10) . Transplantation of wild-type female cells resulted nitrogen-cooled 2-methylbutane, and then cryosectioned in greater number of dystrophin + myocytes in the gasto 10 µm thickness. trocnemius muscle of mdx mice (model for Duchenne
Cell Transplantation to Infarcted Myocardium muscular dystrophy lacking expression of dystrophin), regardless of the sex of the recipient (10) . Female recipiFifty male immunodeficient C57BL/6J-Prkdc scid mice were bred for the current study. Infarcted mice were ranents were also shown to have more dystrophin + myocytes after transplantation than male recipients with domly allocated by a blinded investigator between the treatment groups (saline, female MDSCs, or male MDSCs), either cell sex. When exploring MDSC-induced osteogenesis, male MDSCs displayed more robust osteogenic and 3 × 10 5 cells total in 30 µl saline were injected into the left ventricular free wall of male SCID mice (13) (14) (15) (16) and chondrogenic differentiation in vitro and in vivo versus female cells, regardless of the sex of the recipient weeks of age) 5 min after the permanent ligation of the left coronary artery (25, 27) . Six weeks after cell injecarea of collagen in five sections per heart normalized to total muscle area within the section using ImageJ softtion, echocardiography was performed by a blinded investigator on the left ventricular short axis view at the ware (NIH). midpapillary muscle level as described previously (25, Staining for Cardiac-Specific Markers 27) to assess cardiac function, and the mice were euthanized and the hearts harvested, flash-frozen in 2-Sections from mdx samples were stained with rabbit anti-dystrophin primary antibody (1:400; Abcam) and methylbutane, and cryosectioned (25, 27) .
Alexafluor 488 donkey anti-rabbit secondary antibody Engraftment (1:300; Molecular Probes) and goat anti-cardiac troponin I (1:25,000; Scripps) with rabbit anti-goat AlexCryosections were fixed in 4% paraformaldehyde and then stained to determine donor cell engraftment. For the afluor 555 (1:200; Molecular Probes). Sections from the infarcted samples were stained with mouse anti-fsMHC noninjury model in mdx mice, the number of dystrophin + myocytes was determined as described previously (9, (1:400; Sigma) and Alexafluor 488 donkey anti-mouse secondary antibody (1:300; Molecular Probes) and goat 15). Briefly, sections were stained for dystrophin with a rabbit anti-dystrophin primary antibody (1:400; Abcam)
anti-cardiac troponin I (1:25,000; Scripps) with rabbit anti-goat Alexafluor 555 (1:200; Molecular Probes) and and Alexafluor 488 donkey anti-rabbit secondary antibody (1:200; Molecular Probes). Nuclei were revealed the number of double-positive cells were counted in three high powered fields per heart. with 4′6-diamidino-2-phenylindol (DAPI) stain (100 ng/ ml; Sigma) and sections were mounted with Gel Mount
Analysis of Angiogenic Factor Secretion Aqueous Mounting Medium (Sigma). The engraftment capacity was determined by counting the number of Five male and female MDSC populations were plated in PM at 50,000 cells/well in six-well collagen type 1-dystrophin + fibers. In the infarction model, heart sections were stained with mouse anti-fast skeletal myosin heavy coated plates. Twenty-four hours later, the medium was switched to DMEM with 1% penicillin/streptomyocin. chain (fsMHC) antibody (1:400; Sigma) and Alexafluor 555 donkey anti-mouse secondary antibody (1:300; MoCells were then cultured for an additional 24 h and the medium was collected and flash-frozen until analysis. lecular Probes) to examine engraftment of the different cell populations. Engraftment was determined by assess-ELISA for mouse VEGF (R&D Systems) was performed according to manufacturer's instructions and as preing the area of fsMHC + cells normalized to the area of the entire muscle section (9).
viously described (27) . The VEGF levels were normalized to cell number as measured by hemocytometer.
Identification of Endothelial Cells Within the Engraftment of Transplanted Cells
Cell Survival Following Oxidative Stress Cells were plated in PM at 1,000 cells/well in a 24-The number of CD31 + cells in the engraftment area was determined by double-staining tissue sections with well collagen type 1-coated plate. Twenty-four hours later, the media was switched to PM with propidium rat anti-CD31 primary antibody (1:300; Sigma) and rabbit anti-dystrophin primary antibody (1:400; Abcam), iodide (PI, 1:500, Sigma) or PM containing 350 µM hydrogen peroxide with PI. The plates were then placed and Alexafluor 488 donkey anti-rabbit secondary antibody (1:200; Molecular Probes) and Alexafluor 555 onto a previously described live cell imaging system (Automated Cell, Inc), and fluorescent and brightfield donkey anti-rat secondary antibody (1:300; Molecular Probes) for the mdx mouse model. The rat anti-CD31 images were taken every 10 min in three fixed locations per well. These images were analyzed using Imageprimary antibody (1:300; Sigma) and mouse anti-fsMHC antibody (1:400; Sigma) were used for the infarcted samViewer software (ACI). Cell proliferation was determined by counting the number of cells present in the ples (25, 27, 28) . Blood vessel formation within the cellinjected areas was determined by the number of CD31 Florescence and brightfield microscopy were performed using either a Nikon Eclipse E800 microscope IMEB Trichrome Stain Kit (IMEB, CA, USA). Trichrome staining was performed according to the manuor Leica DMIRB inverted microscope equipped with a Retiga digital camera and Northern Eclipse software facturer's guidelines and as previously described (25, 27) . The sections were then assessed for the percentage (version 6.0, Empix). Image analysis was performed us-ing Northern Eclipse software or Image J software ( Fig. 2A and B) . There was no difference between male and female cells (male cells: 17 ± 3 CD31 + structures, (available from NIH).
female cells: 14 ± 2, Fig. 2A ). No differences were Statistical Analysis noted between the sex of the MDSCs or recipient with respect to the number of CD31 + structures in the Data are summarized as mean and SD. Statistically dystrophin + areas (male cells: 17 ± 3, female cells: 13 ± significant differences between groups were determined 2, p = 0.26, male recipient: 15 ± 3, female recipient: 14 ± using a t-test for mdx studies (Microsoft Excel) or one-3, p = 0.725, Fig. 2B ). We also noted no correlation beway or two-way ANOVA (SigmaStat) as appropriate for tween the density of dystrophin + myocytes and the numthe infarction model. In the event significant differences ber of endothelial cells (endothelial cells in high dyswere detected using ANOVA, the appropriate multiple trophin + regions: 17 ± 3, endothelial cells in low dystrophin + comparisons test was used for post hoc analysis (Tukey regions: 12 ± 2, p = 0.23, Fig. 2B ). Thus, angiogenesis test).
within the implanted region did not appear to be affected RESULTS by the sex of MDSCs and recipient mice or the efficiency of engraftment of MDSCs.
Sex-Related MDSC Fate Following Implantation Into the Nonischemic mdx Heart Sex-Related MDSC Fate in a Myocardial Infarct Model Survival and Engraftment of MDSCs in the mdx
Cardiac Function. We measured cardiac function usHeart. To determine whether cell and recipient sex ing transthoracic echocardiography in SCID mice 6 were critical determining factors in engraftment effiweeks following myocardial infarction and MDSC imciency of dystrophin + cells in the myocardium, five male plantation. Animal groups were divided into recipients and five female MDSC populations were injected into treated with male MDSCs, female MDSCs, or saline the hearts of both male and female mdx mice. Two alone. We noted no difference in left ventricular fracweeks after cell transplantation, dystrophin + myocytes tional area change (FAC) between cell-injected hearts were observed within the hearts of all animals injected based on MDSC sex; however, male and female cells with MDSCs ( Fig. 1A and B) . The regeneration index were significantly better than saline controls (23.2 ± (RI) revealed variability in MDSC engraftment in car-1.3% for male cells, 21.5 ± 1.1% for female cells, and diac muscle, with cell populations varying between ap-13.1 ± 0.8% for saline, p < 0.05) (Fig. 3A) . Postinfarcproximately 100 to over 2,000 dystrophin , p < 0.05) (Fig. 3B ) displayed 172 dystrophin + fibers in male recipients versus 1,069 ± similar trends. 146 dystrophin + fibers in female recipients (Fig. 1C) . Cardiac Scar Tissue Remodeling. The amount of When the sex of the cell was matched with that of the collagen formed following myocardial injury influences host, the number of dystrophin + myocytes was slightly systolic and diastolic function as well as functional reincreased (sex matched: 1,167 ± 178, sex mismatched: covery (35) . Using standard measures of cardiac scar 838 ± 107, p = 0.12). Very low levels of differentiation formation (collagen staining by Masson's trichrome and of implanted MDSCs toward a cardiac phenotype, avercalculation of the ratio of healthy LV to LV scar), we aging less than 1% of injected cells, were seen with all noted that saline-injected hearts had very large scar tis-MDSC populations, regardless of sex or number of sue area ratios 6 weeks following myocardial infarction dystrophin + myocytes, which is consistent with pre-(65.0 ± 5.1%) (Fig. 4 ). MDSCs were found to have suviously published results (25, 28) . Overall, there was no perior engrafting abilities compared with saline injected; difference in the number of engrafted dystrophin + myohowever, sex did not influence postinfarction scar inhicytes based either on the sex of the MDSCs or the sex bition, as all cell-injected groups had significantly of the recipient.
smaller scar tissue area ratios (male cells: 35.2 ± 5.4%, Fig. 4B ; female cells: 35.7 ± 6.9%, Fig. 4C ; p < 0.05 the mdx Heart. MDSC implantation triggers angiogencompared to saline, Fig. 4D ). esis during cardiac remodeling following injury (25, 27) . At 2 weeks post-cell transplantation, we measured the Sex-Related MDSC VEGF Secretion. We determined VEGF secretion into cell culture supernatant for 24 h number of endothelial cells within the dystrophin + cell engraftment zones for all animals injected with MDSCs of serum starvation due to the critical role of VEGF in postinfarction angiogenesis. No difference in VEGF secharacteristics in response to oxidative stress (Fig. 6 ), which correlates to the similar levels of survival and carcretion between male and female MDSCs was noted (male: 623 ± 200 pg/ml/10 6 cells, female: 752 ± 143, p = 0.58) diac engraftment for male and female cells seen in vivo in both the mdx and myocardial infarction (MI) mouse (Fig. 5A) . When subjected to oxidative stress after treatment with hydrogen peroxide, all cells increased their models. production of VEGF, regardless of cell sex (male cells: Donor Cell Engraftment and Differentiation. We 1,387 ± 389 pg/ml/10 6 cells, female cells: 1,240 ± 233). noted a lack of difference in the degree of MDSC enAngiogenesis. No difference in blood vessel formagraftment in postinfarction SCID LV myocardium based tion was noted in the engraftment areas based on MDSC on the sex of implanted MDSCs at 6 weeks (male cells: sex (male cells: 10 ± 1 CD31 + structures, female cells: 27.2 ± 3.8%, female cells: 25.2 ± 3.9%) (Fig. 6B) . As 11 ± 1, p = 0.37) (Fig. 5B) . Outside of the engraftment noted in previous studies, we found less than 1% of imarea, there was again no difference between MDSC planted MDSCs expressed cardiac markers (male cells: sexes. However, there was a trend that MDSC injection, 0.2 ± 0.2%, female cells: 0.3 ± 0.1%), with the vast maregardless of cell sex, induced greater levels of neovasjority maintaining expression of skeletal muscle markers cularization than saline injection at the 6-week time (25, 27) . The engraftment and regeneration seen in the point (PBS: 34 ± 4 CD31 + structures, male cells: 43 ± 7, infarction model differed from the noninfarcted mdx female cells: 54 ± 9) (Fig. 5C) . These results support the model, and that is likely due to the time points examrole for MDSCs in inducing neovascularization versus a ined, the different number of injected cells, and presence recipient response.
Sex Does Not Influence Vascularization of MDSCs in
of injury in the infarction model. Cell Survival After Oxidative Stress. MDSCs have a DISCUSSION superior ability to survive oxidative stress compared to myoblasts (25) , and this seems to be related to the higher Cell transplantation is considered to be a potential therapy for cardiac repair after injury; however, there is regeneration capacity in skeletal and cardiac muscle. Both male and female MDSCs display similar survival still debate as to how the repair takes place and what factors play a critical role. Some groups have demonwe hypothesize that this difference may be due to the different muscle environment found in the heart, includstrated that stem cells can differentiate into cardiomyocytes in situ (19), thereby enacting repair, whereas othing cyclic mechanical strain and the biochemical makeup of infarcted myocardium. We have demonstrated that ers have shown that paracrine mechanisms provide cardioprotection (32,34). Up until recently, cell sex was transplantation of both male and female murine MDSCs attenuated functional deterioration after myocardial innot a factor for consideration in cell transplantation, and results seem to be dependent on injury model, cell type, farction, and we observed that cardiac repair using MDSCs does not appear to be dependent on cell sex. and time points examined (4, 6) . Previous results from our laboratory indicate that cell sex should be considThere was no difference when examining cardiac function after cell transplantation, engraftment capacity, scar ered for muscle, cartilage, and bone regeneration. These experiments demonstrated that female MDSCs are better tissue formation, or coexpression of cardiac phenotype and induction of angiogenesis between the male and feat engrafting into skeletal muscle, while male cells are more osteogenic and chondrogenic (5, 10) . Other groups male cells. These results suggest that the recovery of postinfarction LV function following MDSC implantahave shown that cell sex is also a factor with mesenchymal stem cell activation and cardiac repair, with female tion is not due to MDSC sex. The classic idea for the mechanism of cardiac cell cells improving heart function to a greater extent (6, 7) . Based on these results, we hypothesized that female therapy is that delivery of the appropriate stem cells would repair the damaged heart via active myocardial muscle-derived cells would be superior for cardiac repair.
regeneration from transdifferentiation of the administered stem cells to the cardiac lineage (24) . However, We observed no difference in the mdx model in the engraftment capacity of MDSCs in the heart based on increasing evidence has led to the recognition of another mechanism of cardiac repair: the paracrine effect. In line sex. This result is in contrast to previously reported results on MDSC transplantation into skeletal muscle, and with this mechanism, MDSCs seem to enact repair differentiate into cardiomyocytes to increase heart function after injury, and this leads to the hypothesis that sex-based differences in MDSCs may only be seen when differentiation toward a specific lineage is required. This idea is supported by sex differences observed with MDSC transplantation for skeletal muscle, where the cells had to differentiate toward skeletal muscle lineages to promote the healing process. There are many issues to consider when examining the influence of sex on stem cell potential, particularly for cardiac repair. Intrinsic and extrinsic cellular mechanisms regulate the balance of self-renewal and differentiation in stem cells (21) . Although we did not find sex differences with MDSCs for cardiac repair, other groups have shown that source sex is relevant for mesenchymal stem cells (6) . Although it was not examined in the mesenchymal paper, we cannot exclude the possibility that a sex difference was seen with these cells due to differential differentiation toward a cardiac phenotype. In our current study, we implanted MDSCs isolated from 3-week-old mice, which could have influenced the results, although cells of the same age were used for previous sex studies in skeletal muscle, cartilage, and bone without negative effect. + myocytes based on cell sex (N = 9-10 per group). (C) Outside of the engraftment areas, both male and female cells had induced more blood vessels than saline controls, but the difference was not significant. through paracrine mechanisms by increasing survival and repair of the recipient cardiac tissue rather than by differentiating into cardiomyocytes. Regeneration of cardiac tissue without cardiac differentiation has also been seen with bone marrow and hematopoietic stem cells used to treat ischemia reperfusion injuries and myocardial infarctions (22,34). Previous results have highlighted the importance of VEGF secretion in cardiac repair (27) , and because both male and female MDSCs secrete similar levels of VEGF, this could help reconcile, at least in part, the lack of a sex difference seen in terms of capillary density in this study. When treating higher expression levels of antioxidants or increased (B) No difference is seen in engraftment at 6 weeks between cell sex or area of fsMHC + myocytes.
VEGF production (27) . In the heart, cells do not need to MDSCs can be used with beneficial effect.
